BACKGROUND AND PURPOSE: Minor stroke and transient ischemic attack portend a significant risk of disability. Three possible mechanisms for this include disability not captured by the National Institutes of Health Stroke Scale, symptom progression, or recurrent stroke. We sought to assess the relative impact of these mechanisms on disability in a population of patients with transient ischemic attack and minor stroke. METHODS: Five hundred ten consecutive minor stroke (National Institutes of Health Stroke Scale<4) or patients with transient ischemic attack who were previously not disabled and had a CT/CT angiography completed within 24 hours of symptom onset were prospectively enrolled. Disability was assessed at 90 days using the modified Rankin Scale. Predictors of disability (modified Rankin Scale≥2) and the relative impact of the initial event versus recurrent events were assessed. RESULTS: Seventy-four of 499 (15%; 95% CI, 12%-18%) patients had a disabled outcome. Baseline factors predicting disability were: age≥60 years, diabetes mellitus, premorbid modified Rankin Scale 1, ongoing symptoms, baseline National Institutes of Health Stroke Scale, CT/CT angiography-positive metric, and diffusion-weighted imaging positivity. In the multivariable analysis ongoing symptoms (OR, 2.4; 95% CI, 1.3-4.4; P=0.004), diabetes mellitus (OR, 2.3; 95% CI, 1.2-4.3; P=0.009), female sex (OR, 1.8; 95% CI, 1.1-3; P=0.025), and CT/CT angiography-positive metric (OR, 2.4; 95% CI, 1.4-4; P=0.001) predicted disability. Of the 463 patients who did not have a recurrent event, 55 were disabled (12%). By contrast 19 of 36 (53%) patients were disabled after a recurrent event (risk ratio, 4.4; 95% CI, 3-6.6; P<0.0001). CONCLUSIONS: We found that a substantial proportion of patients with transient ischemic attack and minor stroke become disabled. In terms of absolute numbers, most patients have disability as a result of their presenting event; however, recurrent events have the largest relative impact on outcome.
BACKGROUND AND PURPOSE: Minor stroke and transient ischemic attack portend a significant risk of disability. Three possible mechanisms for this include disability not captured by the National Institutes of Health Stroke Scale, symptom progression, or recurrent stroke. We sought to assess the relative impact of these mechanisms on disability in a population of patients with transient ischemic attack and minor stroke. METHODS: Five hundred ten consecutive minor stroke (National Institutes of Health Stroke Scale<4) or patients with transient ischemic attack who were previously not disabled and had a CT/CT angiography completed within 24 hours of symptom onset were prospectively enrolled. Disability was assessed at 90 days using the modified Rankin Scale. Predictors of disability (modified Rankin Scale≥2) and the relative impact of the initial event versus recurrent events were assessed. RESULTS: Seventy-four of 499 (15%; 95% CI, 12%-18%) patients had a disabled outcome. Baseline factors predicting disability were: age≥60 years, diabetes mellitus, premorbid modified Rankin Scale 1, ongoing symptoms, baseline National Institutes of Health Stroke Scale, CT/CT angiography-positive metric, and diffusion-weighted imaging positivity. In the multivariable analysis ongoing symptoms (OR, 2.4; 95% CI, 1.3-4.4; P=0.004), diabetes mellitus (OR, 2.3; 95% CI, 1.2-4.3; P=0.009), female sex (OR, 1.8; 95% CI, 1.1-3; P=0.025), and CT/CT angiography-positive metric (OR, 2.4; 95% CI, 1.4-4; P=0.001) predicted disability. Of the 463 patients who did not have a recurrent event, 55 were disabled (12%). By contrast 19 of 36 (53%) patients were disabled after a recurrent event (risk ratio, 4.4; 95% CI, 3-6.6; P<0.0001). CONCLUSIONS: We found that a substantial proportion of patients with transient ischemic attack and minor stroke become disabled. In terms of absolute numbers, most patients have disability as a result of their presenting event; however, recurrent events have the largest relative impact on outcome.
Authors: N Asdaghi; J I Coulter; J Modi; M C Camden; A Qazi; M Goyal; T Rundek; S B Coutts Journal: AJNR Am J Neuroradiol Date: 2015-04-23 Impact factor: 3.825
Authors: Brett Cucchiara; Jordan Elm; J Donald Easton; Shelagh B Coutts; Joshua Z Willey; Michelle H Biros; Michael A Ross; S Claiborne Johnston Journal: Stroke Date: 2020-02-12 Impact factor: 7.914
Authors: Daniel J Beard; Damian D McLeod; Caitlin L Logan; Lucy A Murtha; Mohammad S Imtiaz; Dirk F van Helden; Neil J Spratt Journal: J Cereb Blood Flow Metab Date: 2015-02-11 Impact factor: 6.200
Authors: Shadi Yaghi; Charlotte Herber; Amelia K Boehme; Howard Andrews; Joshua Z Willey; Sara K Rostanski; Matthew Siket; Mahesh V Jayaraman; Ryan A McTaggart; Karen L Furie; Randolph S Marshall; Ronald M Lazar; Bernadette Boden-Albala Journal: J Neuroimaging Date: 2017-01-09 Impact factor: 2.486
Authors: Luca Saba; Michele Anzidei; Mario Piga; Federica Ciolina; Lorenzo Mannelli; Carlo Catalano; Jasjit S Suri; Eytan Raz Journal: Cardiovasc Diagn Ther Date: 2014-06